RICHMOND, VA – March 30, 2021– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 12 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
Letters of Intent (LOI) must be received by June 15, 2021 at 5:00 PM EDT. Projects that meet criteria will be invited to submit a full application by July 22, 2021. Applications will be reviewed and scored by an independent review team of scientists, venture capitalists and CEOs of Virginia-based life science companies. The top eight applicant teams will be invited to virtually present their proposal on Wednesday, September 8, 2021. Awards will be announced at the end of September 2021. The LOI submission form, along with funding criteria and frequently asked questions, are available on the Virginia Catalyst website (www.virginiacatalyst.org/apply.html).
Read the full press release here